| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to compound of formula (Ip)or (Ip)or its pharmaceutically acceptable salt, where Grepresents (C-C)alkyl, (C-C)alkoxy, (C-C)halogenalkyl, (C-C)halogenalkoxy, halogen, cyano or nitro; n equals 0; Grepresents (C-C)cycloalkyl or (C-C)cycloalkyl(C-C)alkyl; Grepresents hydrogen; Rrepresents methyl or ethyl; Rrepresents phenyl or fluorophenyl; and Rrepresents 2-hydroxy-2-methylpropyl or 2-methyl-2-cyanopropyl.EFFECT: invention relates to application of compound of formula (Ipand Ip) for manufacturing medication or pharmaceutical composition, intended for treating a person with disease or state, selected from type II diabetes mellitus, obesity, glucose intolerance, hyperglycemias, hyperlipidemis, insulin resistance, decrease of cognitive functions and dyslipidemia.5 cl, 6 tbl, 107 ex |
